Related references
Note: Only part of the references are listed.Universal Marker and Detection Tool for Human Sarcoma Circulating Tumor Cells
Arun Satelli et al.
CANCER RESEARCH (2014)
Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
Xiang Chen et al.
CELL REPORTS (2014)
Survival of pediatric patients after relapsed osteosarcoma: The St. Jude Children's Research Hospital experience
Sarah E. S. Leary et al.
CANCER (2013)
Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials
J. S. Whelan et al.
ANNALS OF ONCOLOGY (2012)
Patients with osteosarcoma with a single pulmonary nodule on computed tomography: a single-institution experience
Israel Fernandez-Pineda et al.
JOURNAL OF PEDIATRIC SURGERY (2012)
Survival after recurrent osteosarcoma: Data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials
Hans Gelderblom et al.
EUROPEAN JOURNAL OF CANCER (2011)
Survival after recurrence of osteosarcoma: A 20-year experience at a single institution
Brian D. Crompton et al.
PEDIATRIC BLOOD & CANCER (2006)
Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma
MT Harting et al.
JOURNAL OF PEDIATRIC SURGERY (2006)
Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy
G Bacci et al.
EUROPEAN JOURNAL OF CANCER (2005)
Resection of recurrent pulmonary metastases in patients with osteosarcoma
A Briccoli et al.
CANCER (2005)
Treatment and outcome of recurrent osteosarcoma: Experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy
G Bacci et al.
ACTA ONCOLOGICA (2005)
Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution
G Bacci et al.
EUROPEAN JOURNAL OF CANCER (2005)
Osteosarcoma: A randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate
PA Meyers et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Osteosarcoma relapse after combined modality therapy:: An analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS)
B Kempf-Bielack et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The patterns of relapse in osteosarcoma: The Memorial Sloan-Kettering Experience
SN Chi et al.
PEDIATRIC BLOOD & CANCER (2004)
Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy
DS Hawkins et al.
CANCER (2003)
Postrelapse survival in osteosarcoma of the extremities: Prognostic factors for long-term survival
S Ferrari et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
